Advertisement
Advertisement

OLMA

OLMA logo

Olema Pharmaceuticals, Inc. Common Stock

12.05
USD
Sponsored
+0.25
+2.12%
Aug 07, 15:59 UTC -4
Closed
exchange

After-Market

11.88

-0.18
-1.45%

Olema Pharmaceuticals, Inc. Common Stock Profile

About

Olema Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It engages in discovery, development and commercialization of therapies for women's cancers. The company's product pipeline includes OP-1250, which is in clinical stage. Olema Pharmaceuticals Inc. is based in San Francisco, California.

Info & Links

CEO

Sean Bohen

Headquarters

780 Brannan Street
San Francisco, CA 94103, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.olema.com

Auditor

Ernst & Young LLP

Share holders

58

Employees

131

Olema Pharmaceuticals, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

1.04B

Enterprise Value

987.70M

Enterprise Value/EBITDA(ttm)

-4.91

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

2.19

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-46.00%

Return on Invested Capital(ttm)

-46.72%

Return on Assets(ttm)

-41.22%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-201.33M

Net Income Available to Common(ttm)

-185.15M

Diluted EPS(ttm)

-2.02

Share Statistics

Beta (5Y Monthly)

2.03

52-Week Change

155.30%

S&P 500 52-Week Change

21.72%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

87.35M

Dividend Yield

0.00%

Float4

76.38M

% Held by Insiders

12.56%

% Held by Institutions

91.78%

Balance Sheet

Total Cash(mrq)

505.35M

Total Cash Per Share(mrq)

5.79

Total Debt(mrq)

3.00M

Total Debt/Equity(mrq)

0.62%

Current Ratio(mrq)

10.88%

Quick Ratio(mrq)

10.88%

Book Value Per Share(mrq)

5.50

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.45

Free Cash Flow(ytd)

-45.99M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement